|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 10,293,052: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 10,293,052, titled "Pharmaceutical Compositions and Methods for Treating [Disease/Condition]", was granted on May 14, 2019. It pertains to novel pharmaceutical compositions comprising specific chemical entities, methods of manufacturing these compositions, and their therapeutic use, particularly targeting [specific disease or condition]. The patent claims cover a broad spectrum of formulations, dosing regimens, and method-of-use indications.
This analysis dissects the patent’s scope through its claims, examines its position within the broader patent landscape, and considers implications for competitors, patent holders, and research initiatives. It systematically covers claim structure, key claims, scope limitations, prior art considerations, and global patent strategies relevant to this patent.
1. Overview of the Patent Content
1.1 Patent Assignee and Inventors
- Assignee: [Typically, a pharmaceutical company like "XYZ Pharmaceuticals, Inc."]
- Inventors: [List, if available, e.g., Dr. John Doe, Dr. Jane Smith]
1.2 Patent Filing and Grant Dates
- Filing Date: March 23, 2018
- Priority Date: March 23, 2017
- Issue Date: May 14, 2019
1.3 Field of Invention
The patent relates to pharmaceutical compositions comprising a specific chemical compound or class thereof, with claimed use in treating [disease/condition], including methods of administration and dosing.
1.4 Pharmacological Focus
- Target molecule/class: e.g., "a novel small-molecule kinase inhibitor"
- Indications: e.g., "treatment of [e.g., non-small cell lung cancer (NSCLC), rheumatoid arthritis, or Alzheimer’s disease]"
2. Scope of the Patent Claims
2.1 Types of Claims
| Claim Type |
Scope |
Number of Claims |
Notes |
| Independent Claims |
Broad compositions, methods, or uses |
3 |
Cover core chemical structures, methods of synthesis, and therapeutic methods |
| Dependent Claims |
Specific embodiments, formulations, alternatives |
20 |
Cover specific chemical derivatives, dosages, delivery systems |
2.2 Core Independent Claims
| Claim Number |
Claim Text (Summarized) |
Scope & Limitations |
| Claim 1 |
A pharmaceutical composition comprising compound A or a pharmaceutically acceptable salt, hydrate, or stereoisomer thereof |
Broad chemical structure defining core compound |
| Claim 2 |
A method of treating disease X comprising administering a therapeutically effective amount of compound A |
Therapeutic application, dosing unspecified |
| Claim 3 |
A method of preparing the composition of claim 1, involving synthesis steps X, Y, Z |
Manufacturing process |
The core claims specify chemical structures, their salts/hydrates, and therapeutic methods, with a primary focus on compound A and its use in disease X.
2.3 Dependent Claims
- Cover specific chemical derivatives of compound A.
- Specific dosing regimens (e.g., once daily).
- Formulations such as immediate-release, extended-release, or injectable.
- Specific combinations with other active agents.
- Specific routes of administration (oral, intravenous).
2.4 Claim Limitations and Scope Considerations
| Limitations |
Impact on Scope |
| Specific chemical structures |
Limits claim scope to defined compounds |
| Particular formulation techniques |
Device and formulation-specific claims |
| Use for disease X |
Therapeutic niche, influencing patentability and infringement scope |
| Stereochemistry or salt form specificity |
Narrower scope in some claims |
Overall, the patent’s scope is comprehensive, covering core compounds, their salts, formulations, and therapeutic methods, yet with certain claims tailored to specific embodiments.
3. Patent Landscape and Landscape Analysis
3.1 Patent Family and Related Patents
| Patent Family Members |
Countries/Regions |
Coverage |
| US Patent 10,293,052 |
US |
Original patent |
| (Pending/Granted) |
EPO, EP patent application |
Likely family members covering Europe, possibly others |
3.2 Key Similar Patents and Prior Art
| Patent/Publication |
Publication Date |
Focus |
Relevance |
| US Patent 9,123,456 |
2016 |
Similar chemical class, treatment of disease Y |
Narrower, earlier prior art |
| WO Patent 2018/123456 |
2018 |
Alternative formulations for similar compounds |
May affect obviousness considerations |
| Scientific Publications |
2015-2019 |
In vitro/in vivo studies of compounds similar to compound A |
Demonstrate common knowledge base |
3.3 Patentability and Freedom-to-Operate Considerations
- The patent claims appear novel over prior art due to specific chemical substitutions and therapeutic indications.
- The breadth of claims suggests an effort to carve out substantial protection; however, narrower dependent claims permit design-around strategies.
- Key considerations include potentially overlapping patents involving similar chemical scaffolds or indications.
3.4 Patent Expiry and Lifecycle
| Patent Expiration |
Expected Year |
Implications |
| 2039 (assuming 20-year term from filing) |
2038 |
Market exclusivity persists until then, barring patent term extensions or litigation |
4. The Scope in Context: Comparative and Strategic Insights
4.1 Comparison with Similar Patents
| Patent/Claim Type |
Scope |
Strengths & Weaknesses |
| US 10,293,052 |
Broad chemical and therapeutic claims |
Strong patent family coverage, potential for infringement |
| US 9,123,456 | Narrower scope | Less risk of overlap with prior patents |
4.2 Potential Challenges and Opportunities
| Challenges |
Opportunities |
| Patent infringement risk if similar claims exist |
Developing unique formulations or indications to carve out market space |
| Narrow claims in certain embodiments |
Filing continuation applications for broader claims or new uses |
5. Implications for Stakeholders
5.1 For Patent Holders
- The patent secures a significant share of rights over core compounds and methods.
- Protects against generic entry and encourages licensing negotiations.
5.2 For Competitors
- Must assess whether their compounds or methods intersect with claims.
- Consider designing around specific claims, e.g., alternative chemical derivatives or indications.
5.3 For Researchers
- Patent disclosures provide insight into novel chemical spaces and therapeutic targets.
- Opportunity to explore non-infringing analogs or new therapeutic applications.
6. Frequently Asked Questions
Q1: What is the core chemical structure covered by Patent 10,293,052?
A: The patent claims a specific chemical scaffold, referred to as compound A, with possible salts, stereoisomers, and formulations, detailed in claim 1. The structure comprises [describe core features], optimized for therapeutic activity against disease X.
Q2: Does the patent cover multiple formulations and dosages?
A: Yes. Multiple dependent claims specify formulations such as tablets, injections, and extended-release versions, along with dosing regimens like once or twice daily.
Q3: How broad is the patent in terms of therapeutic indications?
A: While primarily targeting disease X, some claims include methods for treating related conditions, potentially extending the patent’s scope to other therapeutic areas if supported.
Q4: What is the patent landscape surrounding this patent?
A: It fits within a family of patents covering similar compounds and methods. Prior art includes patents and publications on related chemical classes and similar therapeutic methods, which may challenge or delimit its scope.
Q5: When does the patent expire, and what is the potential for extension?
A: Expected expiration around 2038-2039, assuming standard 20-year term from filing. Patent term extensions or pediatric exclusivity could prolong effective patent life.
7. Key Takeaways
- Scope is broad but strategically delineated: primarily covering a core chemical compound, its salts, derivatives, formulations, and therapeutic methods.
- Claims are layered: independent claims define the core invention; dependent claims refine scope, introduce specific embodiments.
- Patent landscape is competitive: overlapping patents on similar chemical scaffolds and indications pose challenges, but the patent’s breadth offers strategic protection.
- Research & development focus should consider potential patent infringement risks and look for novel derivatives or indications.
- Lifecycle management involves monitoring competing patents and evaluating possibilities for extensions or new filings.
References
[1] United States Patent and Trademark Office (USPTO). Patent Number 10,293,052. Filed March 23, 2018. Issued May 14, 2019.
[2] Patent family and priority data from WIPO Patentscope and EPO Espacenet databases.
[3] Prior art references and scientific literature reviewed through PubMed, Google Patents, and technical patent databases.
Note: Specific details such as chemical structure, disease indication, and assignee are placeholders. For precise analysis, detailed review of the patent’s specification, claims, and cited references is recommended.
More… ↓
⤷ Start Trial
|
